Moderna CEO says mpox vaccine is 'fantastic.' It may never see the market Fierce Biotech Layoff Tracker: Layoffs strike 119 companies in 2022 Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect Belharra's wave catches Genentech in $130M launch for new drug discovery engine Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV specialist's list of partners Geron eyes 2024 US launch for MDS drug after phase 3 trial shows easing of transfusion burden Gilead hopes to evoke ideas for new autoimmune treatments with $659M deal Hummingbird Bio inks $150M licensing deal with Synaffix for ADC tech Vera finally notches a win for Merck KGaA castoff in autoimmune kidney disease Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal |